In CML, activation of the PI3K pathway has been linked to the BCR-ABL tyrosine kinase, the hallmark of CML which is also present in approximately 25% of adult ALL patients, coinciding with the presence of the Philadelphia (Ph) chromosome [3,8,9]. The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.